BUSCARINO, MICHELA
 Distribuzione geografica
Continente #
NA - Nord America 2.832
AS - Asia 1.632
EU - Europa 1.460
SA - Sud America 124
Continente sconosciuto - Info sul continente non disponibili 120
AF - Africa 34
OC - Oceania 16
Totale 6.218
Nazione #
US - Stati Uniti d'America 2.758
CN - Cina 719
SG - Singapore 399
IT - Italia 395
DE - Germania 201
GB - Regno Unito 150
FR - Francia 110
JP - Giappone 101
VN - Vietnam 99
BR - Brasile 94
FI - Finlandia 93
IE - Irlanda 69
IN - India 68
KR - Corea 65
DK - Danimarca 62
HK - Hong Kong 62
CA - Canada 51
NL - Olanda 51
SE - Svezia 46
ES - Italia 41
PL - Polonia 37
BE - Belgio 34
UA - Ucraina 30
TR - Turchia 25
AT - Austria 24
TW - Taiwan 24
CH - Svizzera 21
ID - Indonesia 17
AR - Argentina 16
NO - Norvegia 16
GR - Grecia 15
RU - Federazione Russa 14
AU - Australia 13
RO - Romania 13
CZ - Repubblica Ceca 9
MA - Marocco 8
MX - Messico 8
MY - Malesia 8
ZA - Sudafrica 8
BD - Bangladesh 6
HU - Ungheria 6
TH - Thailandia 6
BG - Bulgaria 5
IR - Iran 5
EC - Ecuador 4
JM - Giamaica 4
MO - Macao, regione amministrativa speciale della Cina 4
PT - Portogallo 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
CO - Colombia 3
IQ - Iraq 3
KE - Kenya 3
LB - Libano 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
HR - Croazia 2
LT - Lituania 2
MK - Macedonia 2
PR - Porto Rico 2
PY - Paraguay 2
SI - Slovenia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
YT - Mayotte 1
Totale 6.100
Città #
Ann Arbor 429
Singapore 242
Ashburn 206
Houston 177
Beijing 149
Fairfield 139
Chandler 125
San Jose 101
Shanghai 93
Woodbridge 76
Wilmington 73
Torino 72
Santa Clara 68
Seattle 63
Hangzhou 61
Dublin 59
Cambridge 55
Boardman 52
New York 50
Tokyo 43
Los Angeles 42
Munich 42
Helsinki 40
The Dalles 39
Dearborn 38
Pisa 37
Milan 35
Ho Chi Minh City 33
Hong Kong 33
Hefei 31
Seoul 30
Turin 29
Guangzhou 28
Amsterdam 24
Villeurbanne 24
Hanoi 23
Redwood City 23
Turku 23
Warsaw 23
Buffalo 22
Dallas 22
Berlin 20
Nyköping 20
Brussels 19
Columbus 19
Jacksonville 18
London 18
Nanjing 17
Rome 17
San Diego 17
Vienna 17
Lauterbourg 16
Paris 16
Taipei 16
Boston 15
Council Bluffs 15
Jakarta 15
Phoenix 15
Wuhan 15
Shenyang 14
Chennai 13
Naples 13
Princeton 13
Changsha 12
Chicago 12
Southend 12
Stuttgart 12
São Paulo 12
Bengaluru 11
Chongqing 11
Lappeenranta 11
Medford 11
Rochester 11
Toronto 11
Irvine 10
Montreal 10
Norwalk 10
Zurich 10
Frankfurt am Main 9
Manchester 9
Chengdu 8
Düsseldorf 8
Genoa 8
Luni 8
Nuremberg 8
Oslo 8
Redmond 8
Silver Spring 8
Utrecht 8
Barcelona 7
Bologna 7
Fremont 7
Miami 7
Moscow 7
Nashville 7
Shenzhen 7
Suzhou 7
Austin 6
Brooklyn 6
Chatsworth 6
Totale 3.662
Nome #
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 1.002
Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor 797
Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer 772
Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer 754
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets 638
INHIBITION OF MEK AND PI3K/MTOR SUPPRESSES TUMOR GROWTH BUT DOES NOT CAUSE TUMOR REGRESSION IN PATIENT-DERIVED XENOGRAFTS OF RAS-MUTANT COLORECTAL CARCINOMAS 453
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer 373
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer 300
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 234
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer 154
Abstract 2913: Emergence of RAS or EGFR mutant clones affects duration of response to EGFR blockade in colorectal cancers 104
The endangered white-clawed crayfish Austropotamobius pallipes (Decapoda, Astacidae) east and west of the Maritime Alps: a result of human translocation? 100
Abstract B110: Heterogeneous genetic alterations emerge during acquired resistance to anti-EGFR therapy in colorectal cancer 97
Abstract 3834: Tracking CAD-ALK gene translocation in urine and plasma of a colorectal cancer patient treated with ALK blockade 95
Abstract C94: Heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer are sensitive to concomitant inhibition of EGFR and MEK 94
Abstract 878: Tumor heterogeneity and lesion-specific response to targeted therapy in colorectal cancer 91
Abstract 616: Blood-based molecular landscapes of resistance to EGFR blockade in colorectal cancer patients 82
Raise and decline of KRAS mutant clones in colorectal cancers (CRCs) treated with multiple rounds of anti-EGFR antibodies 78
Totale 6.218
Categoria #
all - tutte 13.903
article - articoli 0
book - libri 0
conference - conferenze 2.116
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.019


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022586 0 83 64 102 24 28 57 45 31 38 74 40
2022/2023451 34 49 15 46 33 71 27 39 58 13 31 35
2023/2024432 48 44 33 20 33 40 31 46 16 32 43 46
2024/2025881 32 46 76 73 115 63 33 44 84 105 91 119
2025/20261.379 160 78 70 152 137 108 220 59 111 87 81 116
2026/202796 67 29 0 0 0 0 0 0 0 0 0 0
Totale 6.218